Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | MAOA | P21397 | 2/20 | 0.51 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.47 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.47 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.46 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.45 |
| ▸ | SCN1A | P35498 | 2/20 | 0.44 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.44 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzocaine SCHEMBL7263677 | 0.91 | LMNA (0.69) | LMNACYP1A2CYP3A4MAOAADRB2 | |
| SCHEMBL8922492 | 0.91 | ALDH1A1 (0.41) | LMNACYP1A2CYP3A4MAOAADRB2 | |
| SCHEMBL6554819 | 0.85 | LMNA (0.59) | LMNACYP1A2CYP3A4MAOAADRB2 | |
| SCHEMBL6917169 | 0.83 | MAPT (0.49) | LMNACYP1A2CYP3A4MAOAADRB2 | |
| SCHEMBL3894587 | 0.83 | PRKCA (0.36) | LMNACYP1A2CYP3A4MAOAADRB2 | |
| SCHEMBL3390 | 0.82 | ALDH1A1 (0.55) | LMNAADRB2ADRB1ADRB3TSHR | |
| SCHEMBL20548908 | 0.82 | LMNA (0.53) | LMNACYP1A2CYP3A4MAOAADRB2 | |
| SCHEMBL29020062 | 0.81 | LMNA (0.46) | LMNACYP1A2CYP3A4MAOAADRB2 | |
| SCHEMBL4529776 | 0.79 | ALDH1A1 (0.50) | LMNACYP3A4TSHRNPC1RAB9A | |
| SCHEMBL248077 | 0.77 | LMNA (0.59) | LMNACYP1A2CYP3A4MAOAADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1891 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4566586-A1 | SKIN-CARE PRODUCT COMPOSITION AND PHARMACEUTICAL COMPOSITION COMPRISING SULFONATED CALIXARENE, AND USE OF SULFONATED CALIXARENE | Calix Biotechnology (Hangzhou) Co., Ltd (CN) | 2025-06-11 | — | — | EP | claimed |
| WO-2024027193-A1 | SKIN-CARE PRODUCT COMPOSITION AND PHARMACEUTICAL COMPOSITION COMPRISING SULFONATED CALIXARENE, AND USE OF SULFONATED CALIXARENE | 苏州隽德生物科技有限公司 | 2024-02-08 | — | — | WO | claimed |
| CN-110917071-B | Core-shell structure flexible bead, preparation method thereof and personal care product comprising core-shell structure flexible bead | 万华化学集团股份有限公司 | 2022-11-08 | — | — | CN | claimed |
| CN-114788791-A | Compositions and methods for improving the appearance of skin | 宝洁公司 | 2022-07-26 | — | — | CN | claimed |
| CN-106536599-B | Methosilylized imine and urethane polymerized benzoate compounds, uses and compositions thereof | 因特奎姆私人控股公司 | 2021-01-12 | — | — | CN | claimed |
| EP-3145981-B1 | SILYLATED IMINE AND CARBAMATE POLYMERIC BENZOATE COMPOUNDS, USES, AND COMPOSITIONS THEREOF | INTERQUIM SA (ES) | 2020-04-29 | — | — | EP | claimed |
| CN-105813626-B | Composition containing carbodiimide compound | 株式会社LG生活健康 | 2019-05-07 | — | — | CN | claimed |
| EP-3100713-B1 | COSMETIC PRODUCT COMPRISING COSMETIC COMPOSITION IMPREGNATED IN HYDROPHOBIC POLYMER FOAM | LG HOUSEHOLD & HEALTH CARE LTD (KR) | 2019-01-23 | — | — | EP | claimed |
| US-10087200-B2 | Silylated imine and carbamate polymeric benzoate compounds, uses, and compositions thereof | INTERQUIM, S.A. (ES) | 2018-10-02 | — | — | US | claimed |
| CN-106061464-B | Include the cosmetics for the cosmetic composition being impregnated in hydrophobic polymer foam | 株式会社LG生活健康 | 2017-09-01 | — | — | CN | claimed |
| US-5632999-A | Sustained release pyriproxifen compositions for parasite control | VIRBAC, INC. (US) | 1997-05-27 | — | — | US | claimed |
| US-5585090-A | MIXTURE OF METAL OXIDE FLAKE AND ULTRAVIOLET ABSORBENTENCAPSULATED POLYMER | THE PROCTER & GAMBLE COMPANY (US) | 1996-12-17 | — | — | US | claimed |
| EP-0503922-B1 | Cosmetics having photoprotection properties | MAX FACTOR KK (JP) | 1995-12-20 | — | — | EP | claimed |
| EP-0503922-A2 | Cosmetics having photoprotection properties | MAX FACTOR K.K. (JP) | 1992-09-16 | — | — | EP | claimed |
| EP-0165329-B1 | LIQUID DETERGENT WITH SUNSCREEN AGENT | SOFT SHEEN PRODUCTS, INC. (US) | 1991-10-30 | — | — | EP | claimed |
| US-5008101-A | Increasing absorbance of ultraviolet light | DOW CORNING CORPORATION (US) | 1991-04-16 | — | — | US | claimed |
| US-4781914-A | POLYGLYCERYL-8 OLEATE, WATERPROOFING | CHARLES OF THE RITZ GROUP LTD. (US) | 1988-11-01 | — | — | US | claimed |
| US-4749563-A | SECONDARY AMIDE OF SATURATED OR UNSATURATED FATTY ACID | CHARLES OF THE RITZ GROUP LTD. (US) | 1988-06-07 | — | — | US | claimed |
| US-4603046-A | TRI(HYDROXYALKYL)RUTOSIDE, HUMECTANTS | CHARLES OF THE RITZ GROUP LTD. (US) | 1986-07-29 | — | — | US | claimed |
| US-4597963-A | Moisture-resistant skin treatment compositions | CHARLES OF THE RITZ GROUP LTD. (US) | 1986-07-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10087200-B2 | Silylated imine and carbamate polymeric benzoate compounds, uses, and compositions thereof | PIR, SIRT5, SI | LMNA 45/4885CYP1A2 784/4885CYP3A4 719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.